DOPTELET is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Akarx, Inc.. The primary component is Avatrombopag Maleate.
| Product ID | 71369-020_0391dc0b-343d-4c13-bb0b-170be31c3a0a |
| NDC | 71369-020 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DOPTELET |
| Generic Name | Avatrombopag Maleate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-05-23 |
| Marketing Category | NDA / NDA |
| Application Number | NDA210238 |
| Labeler Name | AkaRx, Inc. |
| Substance Name | AVATROMBOPAG MALEATE |
| Active Ingredient Strength | 20 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2018-05-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA210238 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-05-23 |
| Marketing Category | NDA |
| Application Number | NDA210238 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-05-23 |
| Marketing Category | NDA |
| Application Number | NDA210238 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-05-23 |
| Marketing Category | NDA |
| Application Number | NDA210238 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-05-23 |
| Marketing Category | NDA |
| Application Number | NDA210238 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-05-23 |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DOPTELET 87501538 5551985 Live/Registered |
AkaRx, Inc. 2017-06-22 |
![]() DOPTELET 86256264 4967107 Live/Registered |
AKARX, INC. 2014-04-18 |